NASDAQ: ADXN
Addex Therapeutics Ltd Earnings Dates, Reports, Calls

Addex Therapeutics earnings were $8.6M for the trailing 12 months ending Dec 31, 2024, with N/A growth year over year. The latest ADXN earnings report on Dec 31, 2024 announced Q4 2024 earnings of -$1.3M, down 25.6% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, ADXN reported annual earnings of $7.8M, with -162.4% growth.

ADXN earnings history

Current Revenue
$455.6k
Current Earnings
$7.8M
Current Profit Margin
1,720.7%

ADXN Return on Equity

Current Company
88.1%
Current Industry
-2%
Current Market
34.1%
ADXN's Return on Equity (88.1%)... subscribe to Premium to read more.
High Return on Equity Performance

ADXN undefined

Current Company
70.8%
Current Industry
-0.4%
ADXN is generating higher Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when ADXN announces earnings.

ADXN undefined

Current Company
71.48%
Current Industry
5.9%
ADXN has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

ADXN vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
ADXN$8.93M$8.60MN/A$0.09
QNRX-$10.35M-$10.45MN/AN/A
BCLI-$10.74M-$11.09MN/A-$2.07
KAPA-$3.56M-$3.54MN/A-$0.28
DWTX-$21.71M-$23.75MN/A-$19.32

Addex Therapeutics Earnings Reports & History FAQ

What were Addex Therapeutics's earnings last quarter?

Addex Therapeutics (NASDAQ: ADXN) reported Q4 2024 earnings per share (EPS) of -$0.01, up 69.44% year over year. Total ADXN earnings for the quarter were -$1.34 million. In the same quarter last year, Addex Therapeutics's earnings per share (EPS) was -$0.04.

If you're new to stock investing, here's how to buy Addex Therapeutics stock.

Is Addex Therapeutics profitable or losing money?

As of the last Addex Therapeutics earnings report, Addex Therapeutics is currently profitable. Addex Therapeutics's net profit (also called net income) for the twelve months ending Dec 31, 2024 was $7.84 million, a 162.38% decrease year over year.

What was ADXN's earnings growth in the past year?

As of Addex Therapeutics's earnings date in Q2 2025, Addex Therapeutics's earnings has grown year over year. ADXN earnings in the past year totalled $8.60 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.